Jay A. Fishman Ltd’s ELITE PHARMACEUTICAL ELI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-60,000
| Closed | -$5.94K | – | 99 |
|
|
2020
Q1 | $5.94K | Buy |
+60,000
| New | +$5.94K | ﹤0.01% | 95 |
|
|
2019
Q4 | – | Sell |
-60,000
| Closed | -$5.14K | – | 85 |
|
|
2019
Q3 | $5.14K | Hold |
60,000
| – | – | ﹤0.01% | 83 |
|
|
2019
Q2 | $2.64K | Hold |
60,000
| – | – | ﹤0.01% | 83 |
|
|
2019
Q1 | $5.94K | Hold |
60,000
| – | – | ﹤0.01% | 84 |
|
|
2018
Q4 | $4.49K | Hold |
60,000
| – | – | ﹤0.01% | 85 |
|
|
2018
Q3 | $5.4K | Hold |
60,000
| – | – | ﹤0.01% | 87 |
|
|
2018
Q2 | $5.4K | Hold |
60,000
| – | – | ﹤0.01% | 86 |
|
|
2018
Q1 | $6K | Hold |
60,000
| – | – | ﹤0.01% | 86 |
|
|
2017
Q4 | $5.52K | Hold |
60,000
| – | – | ﹤0.01% | 90 |
|
|
2017
Q3 | $6.06K | Hold |
60,000
| – | – | ﹤0.01% | 93 |
|
|
2017
Q2 | $11.3K | Hold |
60,000
| – | – | ﹤0.01% | 92 |
|
|
2017
Q1 | $8.87K | Hold |
60,000
| – | – | ﹤0.01% | 94 |
|
|
2016
Q4 | $9.12K | Hold |
60,000
| – | – | ﹤0.01% | 93 |
|
|
2016
Q3 | $10.6K | Hold |
60,000
| – | – | ﹤0.01% | 85 |
|
|
2016
Q2 | $19.5K | Hold |
60,000
| – | – | ﹤0.01% | 84 |
|
|
2016
Q1 | $18.6K | Hold |
60,000
| – | – | ﹤0.01% | 88 |
|
|
2015
Q4 | $24.5K | Hold |
60,000
| – | – | 0.01% | 92 |
|
|
2015
Q3 | $13.8K | Hold |
60,000
| – | – | ﹤0.01% | 90 |
|
|
2015
Q2 | $12K | Hold |
60,000
| – | – | ﹤0.01% | 95 |
|
|
2015
Q1 | $14.7K | Hold |
60,000
| – | – | ﹤0.01% | 101 |
|
|
2014
Q4 | $13.6K | Hold |
60,000
| – | – | ﹤0.01% | 92 |
|
|
2014
Q3 | $19.3K | Hold |
60,000
| – | – | ﹤0.01% | 88 |
|
|
2014
Q2 | $25.5K | Hold |
60,000
| – | – | 0.01% | 91 |
|
|
2014
Q1 | $24.6K | Hold |
60,000
| – | – | 0.01% | 92 |
|
|
2013
Q4 | $7.2K | Hold |
60,000
| – | – | ﹤0.01% | 91 |
|
|
2013
Q3 | $7.43K | Hold |
60,000
| – | – | ﹤0.01% | 95 |
|
|
2013
Q2 | $4.32K | Buy |
+60,000
| New | +$4.32K | ﹤0.01% | 95 |
|
Other funds holding ELI
Jay A. Fishman Ltd's ELI Position: Q2 2020 in Review
Jay A. Fishman Ltd sold out of ELITE PHARMACEUTICAL (ELI) in Q2 2020, closing a stake of 60,000 shares — an estimated $5.94K sold.
Jay A. Fishman Ltd first reported a position in ELI in Q2 2013 and held it in 27 quarters. The position peaked at $25.5K in Q2 2014. 1 fund tracked by Wall St. Rank holds ELI as of Q2 2020.
- Jay A. Fishman Ltd reported no remaining ELITE PHARMACEUTICAL position as of Q2 2020 after selling out during the quarter.
- Jay A. Fishman Ltd sold 60,000 ELITE PHARMACEUTICAL shares in Q2 2020, an estimated $5.94K.
- Jay A. Fishman Ltd first reported a position in ELITE PHARMACEUTICAL in Q2 2013 and held it in 27 quarters.
- Jay A. Fishman Ltd's ELITE PHARMACEUTICAL position peaked at $25.5K in Q2 2014.
- 1 fund tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q2 2020.
Based on Jay A. Fishman Ltd's 13F filing for Q2 2020, filed 10 Aug 2020.